Financial insights of AVTX

MyFinsight

For the quarter ending 2026-03-31.

Income Statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Total revenues, net-Product	-	-	0	-
Total revenues, net	-	59*	0	-
Cost of product sales	-	0*	0	0
Research and development	14,047	8,540*	13,621	14,074
Acquired in-process research and development	-	0*	0	0
General and administrative	6,854	6,672*	5,577	5,242
Excess of initial warrant fair value over private placement proceeds	-	0*	0	0
Total operating expenses	20,901	15,211*	19,198	19,316
Change in fair value of warrant liability	-	0*	0	0
Loss from operations	-20,901	-15,152*	-19,198	-19,316
Private placement transaction costs	-	0*	0	0
Other expense, net	-	-	-3	-5
Change in fair value of derivative liability	480	13,083*	12,530	2,530
Interest income, net	803	1,023*	1,117	1,102
Total other income, net	1,283	14,105*	-11,416	-1,433
Loss before taxes	-19,618	-1,048*	-30,614	-20,749
Income tax expense	12	125*	11	16
Net loss	-19,630	-1,173*	-30,625	-20,765
Unrealized loss on investments, net	-74	7*	75	-34
Comprehensive loss	-19,704	-1,167	-30,550	-20,799

Basic EPS	-0.98	-0.076	-2.19	-1.92
Diluted EPS	-0.98	-0.076	-2.19	-1.92
Basic Average Shares	20,106,925	15,384,279	14,000,451	10,829,760
Diluted Average Shares	20,106,925	15,384,279	14,000,451	10,829,760

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.